Esomeprazole Magnesium
NDC Package 0615-8396-39

11-digit billing NDC: 00615839639

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Esomeprazole Magnesium is delayed-release capsules are contraindicated in patients with known hypersensitivity to substituted benzimidazoles or to any component of the formulation. Marketed by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, this product is identified by NDC 0615-8396 and is authorized under FDA application ANDA205606.

Identification & Billing

NDC Package Code
0615-8396-39
Package Description
30 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
00615839639

Clinical Specifications

Proprietary Name
Esomeprazole Magnesium
Dosage Form
-
Usage Information
Esomeprazole magnesium delayed-release capsules are contraindicated in patients with known hypersensitivity to substituted benzimidazoles or to any component of the formulation. Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis, and urticaria [see Warnings and Precautions (5.2), Adverse Reactions (6)].For information about contraindications of antibacterial agents (clarithromycin and amoxicillin) indicated in combination with esomeprazole magnesium delayed-release capsules, refer to the CONTRAINDICATIONS section of their package inserts.

Regulatory & Marketing

Labeler Name
Ncs Healthcare Of Ky, Llc Dba Vangard Labs
FDA Application #
ANDA205606
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-21-2016
End Marketing Date
05-31-2026
Listing Expiration
05-31-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0615-8396-39 identifies a specific commercial package of 30 capsule, delayed release in 1 blister pack of Esomeprazole Magnesium, labeled by Ncs Healthcare Of Ky, Llc Dba Vangard Labs. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ncs Healthcare Of Ky, Llc Dba Vangard Labs on April 21, 2016. The current certification is valid through May 31, 2026.

How is this Ncs Healthcare Of Ky, Llc Dba Vangard Labs product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00615839639. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0615-8396-39
11-Digit CMS (5-4-2)
00615-8396-39

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.